Back to Organizations
Recursion
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Salt Lake City, United States
Current Funding Stage
Series DCurrent recognized equity stage. The rounds below remain the historical funding record.
Funding Rounds
Funding Round: Underwritten public offering
Funding Date: 26 Jun, 2024
Raised Amount: $200M
Funding Round: Private investment in public equity (PIPE)
Funding Date: 12 Jul, 2023
Raised Amount: $50M
Funding Round: Initial public offering
Funding Date: 20 Apr, 2021
Raised Amount: $502M
Funding Round: Series D
Funding Date: 9 Sep, 2020
Raised Amount: $239M